A Telethon Kids Institute Website
Find out what we are researching!
Do you mean
A phase 3 multi-centre randomised placebo-controlled study of azithromycin in the primary prevention of radiologically-defined bronchiectasis in infants with cystic fibrosis.
The purpose of this study is to see if we can prevent or delay the onset of lung disease in children with CF by giving them Azithromycin from when they are very young.
Azithromycin is a medicine that is normally used to treat infections in the body that are caused by bacteria.
When researchers gave Azithromycin to older children and adults with CF they discovered that it helped their lung health.
Recruitment is now complete.
Our target of 130 participants has been reached.
For general inquiries, give us a call on +61 8 6319 1000 or email us at email@example.com.